Trinity Biotech | TRIB - Equity Capital And Reserves


Trinity Biotech reported $-71.98M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Bayer EUR 29.71B 863M Jun/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
EDAP TMS EUR 10.1M 13.22M Mar/2026
J&J USD 84.97B 3.78B Jun/2026
Mesa Laboratories USD 186.69M 8.22M Dec/2025
OraSure Technologies USD 317.78M 4.45M Jun/2026
Plus Therapeutics USD 5.46M 6.5M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Siemens EUR 68.26B 3.87B Jun/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Tosoh JPY 841.22B 9.43B Jun/2026
Trinity Biotech USD -71.98M 17.26M Dec/2025
Veracyte USD 1.39B 44M Jun/2026